{"id":"anti-diabetic-medications","safety":{"commonSideEffects":[{"rate":null,"effect":"Hypoglycemia"},{"rate":null,"effect":"Gastrointestinal disturbances"},{"rate":null,"effect":"Weight gain"},{"rate":null,"effect":"Lactic acidosis (metformin)"},{"rate":null,"effect":"Urinary tract infections (SGLT2 inhibitors)"}]},"_chembl":{"chemblId":"CHEMBL2108941","moleculeType":"Unknown"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Anti-diabetic medications represent a broad class of drugs with multiple distinct mechanisms of action. These include insulin secretagogues (stimulating pancreatic beta cells), biguanides (reducing hepatic glucose output), thiazolidinediones (improving peripheral insulin sensitivity), DPP-4 inhibitors (prolonging incretin action), GLP-1 agonists (enhancing glucose-dependent insulin secretion), and SGLT2 inhibitors (promoting urinary glucose excretion). The specific mechanism depends on the individual drug within this class.","oneSentence":"Anti-diabetic medications work through various mechanisms to lower blood glucose levels by enhancing insulin secretion, improving insulin sensitivity, or reducing hepatic glucose production.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T00:27:24.667Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Type 2 diabetes mellitus"},{"name":"Type 1 diabetes mellitus (insulin-based therapies)"}]},"trialDetails":[{"nctId":"NCT06930495","phase":"","title":"The Effect of Adiposity on Muscle and Microvascular Function in HFpEF","status":"ENROLLING_BY_INVITATION","sponsor":"University of Texas Southwestern Medical Center","startDate":"2024-12-10","conditions":"Heart Failure With Preserved Ejection Fraction (HFPEF)","enrollment":95},{"nctId":"NCT07475065","phase":"PHASE2, PHASE3","title":"The Effect of Oral DLBS1033 in Patients With Diabetic Polyneuropathy","status":"NOT_YET_RECRUITING","sponsor":"Universitas Sebelas Maret","startDate":"2026-03-01","conditions":"Diabetic Polyneuropathy, Peripheral Nervous System Diseases, Peripheral Neuropathy","enrollment":34},{"nctId":"NCT07456774","phase":"","title":"A Two-armed Real-world Study of Ozempic (OW Semaglutide) to Evaluate Its Adherence and Persistence Compared With Other Anti-diabetic Drugs Among Adult T2DM Patients in China","status":"NOT_YET_RECRUITING","sponsor":"Novo Nordisk A/S","startDate":"2026-02-13","conditions":"Type 2 Diabetes","enrollment":100000},{"nctId":"NCT04416269","phase":"PHASE4","title":"Oral Anti Diabetic Agents in the Hospital","status":"ACTIVE_NOT_RECRUITING","sponsor":"Emory University","startDate":"2020-08-07","conditions":"Diabetes Mellitus","enrollment":255},{"nctId":"NCT04503551","phase":"PHASE3","title":"A Multicenter, Randomized Study in Participants With Diabetic Retinopathy Without Center-involved Diabetic Macular Edema To Evaluate the Efficacy, Safety, and Pharmacokinetics of Ranibizumab Delivered Via the Port Delivery System Relative to the Comparator Arm","status":"ACTIVE_NOT_RECRUITING","sponsor":"Hoffmann-La Roche","startDate":"2020-08-10","conditions":"Diabetic Retinopathy","enrollment":174},{"nctId":"NCT05937230","phase":"","title":"Drug-coated Balloons and Drug-eluting Stents in Diabetic Patients","status":"ACTIVE_NOT_RECRUITING","sponsor":"Xijing Hospital","startDate":"2015-06-01","conditions":"Coronary Heart Disease, Angioplasty, Balloon","enrollment":1500},{"nctId":"NCT06263673","phase":"PHASE4","title":"Anti-Diabetic Medications to Fight PD and LBD","status":"COMPLETED","sponsor":"Mayo Clinic","startDate":"2024-05-07","conditions":"Lewy Body Dementia, Parkinson Disease","enrollment":18},{"nctId":"NCT07351786","phase":"","title":"Impact of the New Generation Anti-diabetic Drugs on Diabetic Retinopathy","status":"RECRUITING","sponsor":"Sara A Belal","startDate":"2025-08-01","conditions":"Diabetes (DM), Retinopathy, Diabetic, Diabetic Retinopathy (DR)","enrollment":70},{"nctId":"NCT06528405","phase":"PHASE2","title":"The Efficacy and Safety of Sodium-glucose Cotransporter 2 Inhibitors in Patients With Acute Kidney Disease","status":"RECRUITING","sponsor":"National Taiwan University Hospital","startDate":"2024-11-21","conditions":"Acute Kidney Injury","enrollment":264},{"nctId":"NCT05831085","phase":"NA","title":"Diabetes-Centered Evaluation of Revascularization Strategy of Functional and Imaging-CombiNEd State-of-the-Art Percutaneous Coronary Intervention or Coronary-Artery Bypass Grafting in Patients With Diabetes Mellitus and Multivessel Coronary Artery Disease","status":"RECRUITING","sponsor":"Duk-Woo Park, MD","startDate":"2024-06-14","conditions":"Coronary Artery Stenosis","enrollment":1500},{"nctId":"NCT07272109","phase":"PHASE3","title":"Active Anti-diabetic Treatment Plus Chemotherapy for Pancreatic Cancer Related Diabetes","status":"NOT_YET_RECRUITING","sponsor":"Fudan University","startDate":"2026-01-01","conditions":"Pancreatic Cancer","enrollment":210},{"nctId":"NCT04770532","phase":"PHASE3","title":"A Research Study to Compare Two Types of Insulin, a New Weekly Insulin, Insulin Icodec and an Available Daily Insulin, Insulin Degludec, in People With Type 2 Diabetes Who Use Daily Insulin","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2021-03-05","conditions":"Diabetes Mellitus, Type 2","enrollment":526},{"nctId":"NCT04460885","phase":"PHASE3","title":"A Research Study to Compare Two Types of Insulin, a New Insulin, Insulin Icodec and an Available Insulin, Insulin Glargine, in People With Type 2 Diabetes Who Have Not Used Insulin Before","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2020-11-25","conditions":"Diabetes Mellitus, Type 2","enrollment":984},{"nctId":"NCT05352815","phase":"PHASE3","title":"A Research Study to See How Well the New Weekly Medicine IcoSema, Which is a Combination of Insulin Icodec and Semaglutide, Controls Blood Sugar Level in People With Type 2 Diabetes Compared to Weekly Insulin Icodec","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2022-06-01","conditions":"Diabetes Mellitus, Type 2","enrollment":1291},{"nctId":"NCT04880850","phase":"PHASE3","title":"A Research Study to Compare Two Types of Insulin, a New Weekly Insulin, Insulin Icodec and an Available Daily Insulin, Insulin Glargine, Both in Combination With Mealtime Insulin, in People With Type 2 Diabetes Who Use Daily Insulin and Mealtime Insulin (ONWARDS 4)","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2021-05-14","conditions":"Diabetes Mellitus, Type 2","enrollment":582},{"nctId":"NCT05013229","phase":"PHASE3","title":"A Research Study to See How Well the New Weekly Medicine IcoSema, Which is a Combination of Insulin Icodec and Semaglutide, Controls Blood Sugar Level in People With Type 2 Diabetes Compared to Insulin Glargine Taken Daily With Insulin Aspart (COMBINE 3)","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2021-11-30","conditions":"Diabetes Mellitus, Type 2","enrollment":679},{"nctId":"NCT06491914","phase":"PHASE3","title":"A Phase 3b, Single-Arm Study of Aflibercept 8 mg Dosed Every 4 Weeks in Adult Participants With Neovascular Age-Related Macular Degeneration (nAMD) or Diabetic Macular Edema (DME)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Regeneron Pharmaceuticals","startDate":"2024-07-24","conditions":"Neovascular Age-Related Macular Degeneration, Diabetic Macular Edema","enrollment":1118},{"nctId":"NCT05697809","phase":"PHASE2","title":"Suprachoroidal Sustained-Release OXU-001 Compared to Intravitreal Ozurdex® in the Treatment of Diabetic Macular Edema","status":"COMPLETED","sponsor":"Oxular Limited","startDate":"2023-08-07","conditions":"Diabetic Macular Edema","enrollment":3},{"nctId":"NCT06269107","phase":"PHASE3","title":"A Research Study to See How Well New Weekly Medicine IcoSema, Which is a Combination of Insulin Icodec and Semaglutide, Controls Blood Sugar Levels in People With Type 2 Diabetes (T2D), Compared to Daily Insulin Glargine (COMBINE 4)","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2024-02-15","conditions":"Type 2 Diabetes","enrollment":485},{"nctId":"NCT04481997","phase":"","title":"Anti-thrombotic and Glucose Lowering Therapy in Diabetic Patients Undergoing PCI","status":"COMPLETED","sponsor":"Associacao para Investigacao e Desenvolvimento da Faculdade de Medicina - CETERA","startDate":"2021-01-11","conditions":"Type2 Diabetes Mellitus, Coronary Heart Disease","enrollment":1000},{"nctId":"NCT06205030","phase":"PHASE4","title":"Efficacy of NOSHINtrial in Diabetic Patients","status":"NOT_YET_RECRUITING","sponsor":"Kerman Medical University","startDate":"2025-09-26","conditions":"Diabetes Mellitus, Type 2, Insulin Resistance","enrollment":70},{"nctId":"NCT06011798","phase":"PHASE2","title":"Assess the Efficacy and Safety of Repeat Intravitreal Injections of Foselutoclax (UBX1325) in Patients With DME (ASPIRE)","status":"COMPLETED","sponsor":"Unity Biotechnology, Inc.","startDate":"2023-08-23","conditions":"Diabetic Macular Edema, Retinal Disease, Macular Edema","enrollment":52},{"nctId":"NCT05169060","phase":"PHASE1, PHASE2","title":"Omega-3 Fatty Acid Lipidomics in Diabetes Peripheral Neuropathy","status":"RECRUITING","sponsor":"University of Iowa","startDate":"2023-06-12","conditions":"Diabetic Neuropathies","enrollment":100},{"nctId":"NCT07065591","phase":"EARLY_PHASE1","title":"Anti-Diabetic Drug, Exercise and Healthy Diet for Knee Osteoarthritis With Overweight/Obesity","status":"NOT_YET_RECRUITING","sponsor":"The University of Hong Kong","startDate":"2025-10-01","conditions":"Osteoarthritis (OA) of the Knee","enrollment":100},{"nctId":"NCT05259033","phase":"PHASE3","title":"A Research Study to See How Well the New Weekly Medicine IcoSema, Which is a Combination of Insulin Icodec and Semaglutide, Controls Blood Sugar Level in People With Type 2 Diabetes Compared to Weekly Semaglutide (COMBINE 2)","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2022-04-11","conditions":"Diabetes Mellitus, Type 2","enrollment":683},{"nctId":"NCT06830096","phase":"NA","title":"Role of KATP Channel Loss in Type 2 Diabetes","status":"RECRUITING","sponsor":"Washington University School of Medicine","startDate":"2025-03-07","conditions":"Obesity and Type 2 Diabetes","enrollment":40},{"nctId":"NCT06845163","phase":"PHASE2","title":"Randomized Clinical Trial to Evaluate the Effect of Dapagliflozin in Patients With Diabetic Macular Edema","status":"RECRUITING","sponsor":"Alexandria University","startDate":"2025-02-08","conditions":"Diabetic Macular Edema, Center-involved Diabetic Macular Edema","enrollment":56},{"nctId":"NCT06476730","phase":"NA","title":"Telerehabilitation Exercise: Effects on Maternal Psychological Health and Delivery Outcomes","status":"COMPLETED","sponsor":"Riphah International University","startDate":"2024-07-01","conditions":"Gestational Diabetes Mellitus in Pregnancy, Gestational Diabetes, Maternal Psychological Distress","enrollment":62},{"nctId":"NCT06480292","phase":"NA","title":"Telerehabilitation Exercise: Effects on Maternal Quality of Life, Fetal and Neonatal Health.","status":"COMPLETED","sponsor":"Riphah International University","startDate":"2024-07-01","conditions":"Gestational Diabetes Mellitus in Pregnancy","enrollment":68},{"nctId":"NCT06452017","phase":"NA","title":"Effects of Telerehabilitation Exercise Program on Maternal Glycemic Control","status":"COMPLETED","sponsor":"Riphah International University","startDate":"2024-06-10","conditions":"Gestational Diabetes Mellitus in Pregnancy","enrollment":70},{"nctId":"NCT03471117","phase":"PHASE4","title":"Pioglitazone to Reduce Sympathetic Overactivity in CKD Patients","status":"RECRUITING","sponsor":"The University of Texas at Arlington","startDate":"2018-04-01","conditions":"Chronic Kidney Diseases","enrollment":28},{"nctId":"NCT06992466","phase":"","title":"Short Term Outcomes After Primary PCI in Diabetic Patients Treated With Insulin Versus Oral Anti-diabetic Drugs","status":"NOT_YET_RECRUITING","sponsor":"Assiut University","startDate":"2025-05-20","conditions":"Diabetes Mellitus, PCI","enrollment":210},{"nctId":"NCT06974422","phase":"NA","title":"Weight Off-loading Training, Cardiovascular Indices, Diabetes","status":"COMPLETED","sponsor":"Umm Al-Qura University","startDate":"2024-08-01","conditions":"Cardiovascular Disease, Diabetes Mellitus Type 2, Peripheral Vascular Disorder Due to Diabetes Mellitus","enrollment":46},{"nctId":"NCT06951087","phase":"PHASE3","title":"Intravitreal and Intracameral DEX in NPDR","status":"ENROLLING_BY_INVITATION","sponsor":"Affiliated Hospital of Nantong University","startDate":"2022-01-31","conditions":"Non-Proliferative Diabetic Retinopathy","enrollment":80},{"nctId":"NCT04451980","phase":"","title":"The HIV, Adipose Tissue Immunology, and Metabolism Study","status":"ACTIVE_NOT_RECRUITING","sponsor":"Vanderbilt University Medical Center","startDate":"2017-08-31","conditions":"Hiv, Diabetes Mellitus, Type 2","enrollment":172},{"nctId":"NCT05698329","phase":"PHASE1","title":"Effect of AIV007 by Periocular Administration in Subjects with Macular Edema Secondary to Neovascular Age-related Macular Degeneration (nAMD) and Diabetic Macular Edema (DME)","status":"ACTIVE_NOT_RECRUITING","sponsor":"AiViva BioPharma, Inc.","startDate":"2023-03-02","conditions":"Neovascular Age-related Macular Degeneration, Diabetic Macular Edema, Macular Edema","enrollment":19},{"nctId":"NCT06821919","phase":"","title":"Impact of Antiglycemic & Immunosuppressive Therapies on NETosis in Diabetes & Kidney Disease (NETs - Neutrophil Traps)","status":"RECRUITING","sponsor":"Western Galilee Hospital-Nahariya","startDate":"2024-05-13","conditions":"Diabetes Mellitus, Kidney Disease","enrollment":70},{"nctId":"NCT06284213","phase":"","title":"Biomarkers for Vascular Contributions to Cognitive Impairment and Dementia Consortium","status":"ACTIVE_NOT_RECRUITING","sponsor":"Massachusetts General Hospital","startDate":"2021-09-29","conditions":"Cognitive Impairment, Dementia","enrollment":1892},{"nctId":"NCT06725238","phase":"","title":"Acute-to-chronic Glycemic Ratio (ACGR) is a Marker of DFUs .","status":"COMPLETED","sponsor":"University of Diyala","startDate":"2024-05-01","conditions":"Diabetic Foot Ulcer (DFU)","enrollment":80},{"nctId":"NCT04795531","phase":"PHASE3","title":"A Research Study to Compare Two Types of Insulin, a New Insulin, Insulin Icodec and an Available Insulin, Insulin Degludec, in People With Type 2 Diabetes Who Have Not Used Insulin Before (ONWARDS 3)","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2021-03-24","conditions":"Diabetes Mellitus, Type 2","enrollment":588},{"nctId":"NCT04469595","phase":"PHASE4","title":"A Study of Intravitreal ILUVIEN® Implant as Baseline Therapy in Patients With Early Diabetic Macular Edema (DME)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Alimera Sciences","startDate":"2020-08-31","conditions":"Diabetic Macular Edema","enrollment":300},{"nctId":"NCT06441591","phase":"PHASE2, PHASE3","title":"Clinical Outcome of Vinpocetine in Diabetic Nephropathy","status":"RECRUITING","sponsor":"Ain Shams University","startDate":"2024-07-10","conditions":"Diabetic Kidney Disease, Diabetic Nephropathies","enrollment":64},{"nctId":"NCT04411693","phase":"PHASE4","title":"Comparative Study of Dexamethasone Implant to Intravitreal Aflibercept in Subjects With Diabetic Macular Edema","status":"COMPLETED","sponsor":"The Cleveland Clinic","startDate":"2020-04-10","conditions":"Diabetic Macular Edema","enrollment":23},{"nctId":"NCT00417716","phase":"PHASE3","title":"Use of Intravitreal Bevacizumab in Patients With Diffuse Diabetic Macular Edema","status":"WITHDRAWN","sponsor":"Asociación para Evitar la Ceguera en México","startDate":"2005-09","conditions":"Diabetes Mellitus Type 2, Diabetic Macular Edema","enrollment":""},{"nctId":"NCT05284344","phase":"","title":"The Impact of Glucotoxicity on Gastric Emptying in Chinese Patients With Newly Diagnosed Type 2 Diabetes","status":"COMPLETED","sponsor":"University of Adelaide","startDate":"2021-01-24","conditions":"Type 2 Diabetes","enrollment":78},{"nctId":"NCT06405178","phase":"PHASE3","title":"Adjuvant Therapy With Letrozole in Induction of Ovulation With Polycystic Ovarian Syndrome","status":"NOT_YET_RECRUITING","sponsor":"Beni-Suef University","startDate":"2024-09-30","conditions":"Polycystic Ovary","enrollment":500},{"nctId":"NCT03321513","phase":"PHASE3","title":"DRCR.Net Aflibercept vs. Bevacizumab + Deferred Aflibercept for the Treatment of CI-DME","status":"COMPLETED","sponsor":"Jaeb Center for Health Research","startDate":"2017-12-07","conditions":"Diabetic Macular Edema","enrollment":270},{"nctId":"NCT04227431","phase":"","title":"A Research Study, Looking at How Tresiba® Works in People With Type 2 Diabetes in Local Clinical Practice in China","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2020-01-17","conditions":"Diabetes Mellitus, Type 2","enrollment":938},{"nctId":"NCT03653091","phase":"NA","title":"Safety & Effectiveness of Duodenal Mucosal Resurfacing (DMR) Using the Revita™ System in Treatment of Type 2 Diabetes","status":"COMPLETED","sponsor":"Fractyl Health Inc.","startDate":"2018-09-28","conditions":"Type 2 Diabetes","enrollment":9},{"nctId":"NCT00455858","phase":"PHASE4","title":"Evaluation of the Glycaemic Control With Insulin Detemir as an add-on to Current Oral Anti-diabetic Drug Treatment in Subjects With Type 2 Diabetes in Korea","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2007-11","conditions":"Diabetes, Diabetes Mellitus, Type 2","enrollment":87},{"nctId":"NCT04575181","phase":"PHASE1","title":"A Clinical Study to Compare the Efficacy and Safety of a Novel Medicine (NNC0268-0965) With Insulin Glargine","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2020-10-21","conditions":"Diabetes Mellitus, Type 2","enrollment":86},{"nctId":"NCT04233801","phase":"PHASE3","title":"A Study to Test How Well Empagliflozin Works in Chinese Patients With Type 2 Diabetes Who Already Take Insulin","status":"COMPLETED","sponsor":"Boehringer Ingelheim","startDate":"2020-04-15","conditions":"Diabetes Mellitus, Type 2","enrollment":219},{"nctId":"NCT01431807","phase":"PHASE3","title":"Long-term Study of SYR-472","status":"COMPLETED","sponsor":"Takeda","startDate":"2011-09-01","conditions":"Diabetes Mellitus","enrollment":680},{"nctId":"NCT06146309","phase":"NA","title":"Assessment Of Peri-papillary Retinal Nerve Fiber Layer Thickness In Patients With Unilateral Branch Retinal Vein Occlusion","status":"COMPLETED","sponsor":"Al-Azhar University","startDate":"2020-12-01","conditions":"Branch Retinal Vein Occlusion","enrollment":60},{"nctId":"NCT03784443","phase":"PHASE2, PHASE3","title":"Combined Ranibizumab and Iluvien for Diabetic Macular Oedema","status":"WITHDRAWN","sponsor":"Imperial College London","startDate":"2019-09-01","conditions":"Diabetic Macular Edema, Diabetes","enrollment":""},{"nctId":"NCT05156021","phase":"NA","title":"A Study on the Treatment Strategy of NVG Secondary to PDR","status":"COMPLETED","sponsor":"Ruijin Hospital","startDate":"2021-12-12","conditions":"Neovascular Glaucoma, Proliferative Diabetic Retinopathy","enrollment":39},{"nctId":"NCT05817097","phase":"","title":"Effect of Dipeptidyl-4 Inhibitors in Reducing Stroke Severity, From HIRA Database","status":"UNKNOWN","sponsor":"Ajou University School of Medicine","startDate":"2023-08","conditions":"Cerebral Infarction, Infarction, Brain, Dipeptidyl-Peptidase IV Inhibitors","enrollment":22119},{"nctId":"NCT05946148","phase":"","title":"Novel Antidiabetic Medications and Their Effect on Liver Steatosis (NAMELS-18)","status":"COMPLETED","sponsor":"National and Kapodistrian University of Athens","startDate":"2018-06-01","conditions":"Non-Alcoholic Fatty Liver Disease, Liver Steatosis","enrollment":78},{"nctId":"NCT03786406","phase":"","title":"An International Survey of the Occurrence of Diseases That Affects the Heart and Blood Vessels Among People With Type 2 Diabetes","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2018-12-03","conditions":"Diabetes Mellitus, Type 2","enrollment":2275},{"nctId":"NCT05005052","phase":"PHASE3","title":"Sulodexide in the Treatment of Chronic Primary Venous Disease of the Lower Extremities","status":"UNKNOWN","sponsor":"Value Outcomes Ltd.","startDate":"2021-11-25","conditions":"Chronic Venous Disease, Chronic Insufficiency Venous","enrollment":290},{"nctId":"NCT05329415","phase":"","title":"Tuberculosis Drug Levels and Continuous Glucose Monitoring in Diabetic Patients","status":"UNKNOWN","sponsor":"London North West Healthcare NHS Trust","startDate":"2022-02-01","conditions":"Tuberculosis, Diabetes Mellitus","enrollment":48},{"nctId":"NCT05333835","phase":"PHASE2","title":"A Trial Comparing the Efficacy and Safety of HR17031 Injection to INS068 Injection and to SHR20004 Injection in Patients With Type 2 Diabetes","status":"UNKNOWN","sponsor":"Jiangsu HengRui Medicine Co., Ltd.","startDate":"2022-07-08","conditions":"Type 2 Diabetes","enrollment":455},{"nctId":"NCT05822674","phase":"","title":"Variable Effects of Anti-diabetics on Stress Hyperglycemia Ratio","status":"COMPLETED","sponsor":"University of Diyala","startDate":"2022-01-01","conditions":"Type 2 Diabetes","enrollment":80},{"nctId":"NCT05822349","phase":"NA","title":"Effect of Using Pictograms on Improving Depression and Anxiety Among Type 2 Diabetic Patients.","status":"UNKNOWN","sponsor":"University of Jordan","startDate":"2023-04-01","conditions":"Type 2 Diabetes","enrollment":204},{"nctId":"NCT03871621","phase":"PHASE4","title":"Left Ventricular Functional Changes of Uncontrolled Diabetes by Dapagliflozin Treatment Trial","status":"COMPLETED","sponsor":"Mackay Memorial Hospital","startDate":"2019-04-01","conditions":"Type 2 Diabetes Mellitus","enrollment":76},{"nctId":"NCT05759884","phase":"NA","title":"Efficacy Analysis of Anti-VEGF Drugs Combined With Micropulse Laser in the Treatment of Diabetic Macular Edema","status":"UNKNOWN","sponsor":"Second Affiliated Hospital, School of Medicine, Zhejiang University","startDate":"2022-02-01","conditions":"Macular Edema Due to Type 2 Diabetes Mellitus","enrollment":40},{"nctId":"NCT04634890","phase":"NA","title":"Bialystok Exercise Study in Diabetes","status":"UNKNOWN","sponsor":"Medical University of Bialystok","startDate":"2016-08-11","conditions":"Type 2 Diabetes, PreDiabetes, Overweight","enrollment":300},{"nctId":"NCT02425501","phase":"","title":"Special Drug Use Investigation of EYLEA for Diabetic Macular Edema","status":"COMPLETED","sponsor":"Bayer","startDate":"2015-01-20","conditions":"Macular Edema","enrollment":646},{"nctId":"NCT05547789","phase":"","title":"Assessment Of Diabetic Maculopathy Changes After Phacoemulsification by Using Optical Coherence Tomography","status":"UNKNOWN","sponsor":"Assiut University","startDate":"2023-03","conditions":"Maculopathy","enrollment":30},{"nctId":"NCT05629806","phase":"PHASE3","title":"Effect of Acarbose and Mixture of Pioglitazone and Metformin in Patients With Type 2 Diabetes","status":"UNKNOWN","sponsor":"Nanjing First Hospital, Nanjing Medical University","startDate":"2022-04-10","conditions":"Type 2 Diabetes, Blood Glucose Fluctuation","enrollment":50},{"nctId":"NCT03714594","phase":"PHASE2","title":"Effects of Dapagliflozin+Saxagliptin in Addition to Metformin v/s Saxagliptin or Dapagliflozin in Patients With DM2.","status":"COMPLETED","sponsor":"University of Pisa","startDate":"2018-07-24","conditions":"Type2 Diabetes Mellitus","enrollment":48},{"nctId":"NCT05558878","phase":"NA","title":"Effect of Ambroxol in Diabetic Peripheral Neuropathy","status":"UNKNOWN","sponsor":"Ain Shams University","startDate":"2022-10-01","conditions":"Diabetic Neuropathy Peripheral","enrollment":80},{"nctId":"NCT05249881","phase":"EARLY_PHASE1","title":"\"Efficacy of Once Weekly GLP 1 Analogue: Semaglutide. A Multicenter Experience From Pakistan.\"","status":"UNKNOWN","sponsor":"Aga Khan University","startDate":"2022-03-10","conditions":"Diabetes Mellitus, Type 2, Weight Change, Body","enrollment":300},{"nctId":"NCT02041234","phase":"PHASE4","title":"Roux-en-Y Gastric Bypass for BMI 27-32 Type 2 Diabetes Versus Best Medical Treatment","status":"COMPLETED","sponsor":"Khoo Teck Puat Hospital","startDate":"2014-02","conditions":"Type II Diabetes in Subjects BMI 27 to 32","enrollment":40},{"nctId":"NCT03486964","phase":"","title":"Use of Incretins in Diabetic Patients","status":"COMPLETED","sponsor":"University of Pavia","startDate":"2018-03-27","conditions":"Diabetes Mellitus, Type 2","enrollment":2234},{"nctId":"NCT05101330","phase":"NA","title":"Impact of Bilingual Prescription Medication Labels Among Elderly Singaporeans","status":"WITHDRAWN","sponsor":"Singapore General Hospital","startDate":"2021-11-01","conditions":"Diabetes Mellitus, Type 2, Hypertension","enrollment":""},{"nctId":"NCT03312478","phase":"PHASE4","title":"Association of Type 1 Diabetes Mellitus in Offsprings With Positive Parental History of Diabetes","status":"COMPLETED","sponsor":"Sanofi","startDate":"2017-10-13","conditions":"Type 1 Diabetes","enrollment":375},{"nctId":"NCT03414736","phase":"PHASE1","title":"A Study on Safety and Tolerability of SAR425899 in Overweight to Obese Subjects and Type 2 Diabetes Mellitus Patients Not Requiring Anti-Diabetic Pharmacotherapy With an Optional 6-month Safety Extension Period","status":"COMPLETED","sponsor":"Sanofi","startDate":"2018-01-19","conditions":"Type 2 Diabetes Mellitus","enrollment":60},{"nctId":"NCT02842359","phase":"PHASE4","title":"Evaluation of the Fixed-dose Combination of Irbesartan/Atorvastatin in Type 2 Diabetic Patients Diagnosed With Hyperlipidemia and Hypertension","status":"COMPLETED","sponsor":"Sanofi","startDate":"2016-08-23","conditions":"Type 2 Diabetes Mellitus","enrollment":11},{"nctId":"NCT05324774","phase":"PHASE3","title":"Efficacy and Safety of 9MW0813 in Subjects With Diabetic Macular Edema","status":"UNKNOWN","sponsor":"Mabwell (Shanghai) Bioscience Co., Ltd.","startDate":"2022-02-28","conditions":"Diabetic Macular Edema","enrollment":346},{"nctId":"NCT05324592","phase":"PHASE1","title":"Safety and Efficacy of 9MW0813 in Subjects With Diabetic Macular Edema","status":"COMPLETED","sponsor":"Mabwell (Shanghai) Bioscience Co., Ltd.","startDate":"2021-02-26","conditions":"Diabetic Macular Edema","enrollment":24},{"nctId":"NCT03434119","phase":"PHASE3","title":"Efficacy and Safety of Soliqua Versus Lantus in Ethnically/Racially Diverse Patients With Type 2 Diabetes Mellitus Inadequately Controlled on Basal Insulin and Oral Antidiabetic Agents","status":"TERMINATED","sponsor":"Sanofi","startDate":"2018-02-20","conditions":"Type 2 Diabetes Mellitus","enrollment":241},{"nctId":"NCT02787551","phase":"PHASE3","title":"Efficacy and Safety of the Insulin Glargine/Lixisenatide Fixed Ratio Combination (FRC) Versus GLP-1 Receptor Agonist in Patients With Type 2 Diabetes, With a FRC Extension Period","status":"COMPLETED","sponsor":"Sanofi","startDate":"2016-07-06","conditions":"Type 2 Diabetes Mellitus","enrollment":514},{"nctId":"NCT04976283","phase":"PHASE4","title":"Effect of Oral Anti-diabetic Medication on Liver Fat in Subjects With Type II Diabetes and Non-alcoholic Fatty Liver","status":"UNKNOWN","sponsor":"Getz Pharma","startDate":"2021-09-15","conditions":"Diabetes Mellitus, Type 2, NASH - Nonalcoholic Steatohepatitis, NAFLD","enrollment":123},{"nctId":"NCT05145140","phase":"PHASE1","title":"A Clinical Intervention Study of Tangningtongluo on Diabetic Foot Ulcer","status":"UNKNOWN","sponsor":"Affiliated Hospital of Nantong University","startDate":"2022-01-15","conditions":"Diabetic Foot Ulcer","enrollment":80},{"nctId":"NCT05272839","phase":"NA","title":"Association Between Natural Hypoglycemic Foods and Blood Sugar Level: A Pilot Study","status":"UNKNOWN","sponsor":"Antenna Foundation","startDate":"2022-04","conditions":"Type II Diabetes","enrollment":124},{"nctId":"NCT04385589","phase":"PHASE4","title":"Dapagliflozin in Diabetic Patients (Type 2) With Decompensated Heart Failure","status":"COMPLETED","sponsor":"Assiut University","startDate":"2020-05-01","conditions":"Heart Failure","enrollment":100},{"nctId":"NCT05041673","phase":"NA","title":"Anti-diabetic Drugs and Fatty Liver Management","status":"UNKNOWN","sponsor":"Alexandria University","startDate":"2021-02-23","conditions":"Fatty Liver, Nonalcoholic, Diabetes Mellitus, Type 2","enrollment":120},{"nctId":"NCT04323462","phase":"PHASE4","title":"Intensive Glycemic Control For Diabetic Foot Ulcer Healing","status":"UNKNOWN","sponsor":"Post Graduate Institute of Medical Education and Research, Chandigarh","startDate":"2021-10-01","conditions":"Diabetic Foot Ulcer","enrollment":326},{"nctId":"NCT05076955","phase":"EARLY_PHASE1","title":"Evaluating the Healing of Diabetic Foot Ulcers With Compounded Anti-Infective Irrigation Therapy","status":"UNKNOWN","sponsor":"University of Mississippi Medical Center","startDate":"2021-03-31","conditions":"Diabetic Foot Ulcer","enrollment":100},{"nctId":"NCT02597101","phase":"PHASE2","title":"Anti-Inflammatory Small Drug Adjunctive Therapy for Type 2 Diabetes","status":"COMPLETED","sponsor":"Nick Giannoukakis, PhD","startDate":"2015-11","conditions":"Type 2 Diabetes Mellitus, Insulin Resistance","enrollment":14},{"nctId":"NCT04856397","phase":"NA","title":"Ozurdex in Suboptimal Diabetic Macular Edema Patients","status":"UNKNOWN","sponsor":"Uptown Eye Specialists","startDate":"2021-05-25","conditions":"Diabetic Macular Edema","enrollment":200},{"nctId":"NCT02874313","phase":"PHASE4","title":"CPAP Effect on the Progression of Diabetic Retinopathy in Patients With Sleep Apnea","status":"COMPLETED","sponsor":"Hospital Universitario La Paz","startDate":"2016-08","conditions":"Diabetic Retinopathy, Sleep Apnea","enrollment":82},{"nctId":"NCT02816762","phase":"PHASE4","title":"CPAP Effect on Albuminuria in Patients With Diabetic Nephropathy and Obstructive Sleep Apnea","status":"COMPLETED","sponsor":"Hospital Universitario La Paz","startDate":"2016-06","conditions":"Diabetic Nephropathy, Sleep Apnea","enrollment":180},{"nctId":"NCT04081766","phase":"NA","title":"Pharmacist-Led Study in Controlling Hypoglycemia in Older Adults With Type 2 Diabetes Mellitus","status":"COMPLETED","sponsor":"University of Lincoln","startDate":"2020-02-09","conditions":"Diabetes Mellitus Type 2 With Hypoglycemia","enrollment":212},{"nctId":"NCT04242511","phase":"","title":"Tuberculosis Drug Levels in Diabetics","status":"UNKNOWN","sponsor":"London North West Healthcare NHS Trust","startDate":"2021-05","conditions":"Tuberculosis, Diabetes Mellitus","enrollment":48},{"nctId":"NCT02911948","phase":"PHASE3","title":"A Double-blinded Trial Comparing the Efficacy and Safety of Insulin Degludec/Liraglutide and Insulin Degludec Both in Combination With Metformin in Japanese Subjects With Type 2 Diabetes Mellitus Inadequately Controlled With Basal or Pre-mix/Combination Insulin Therapy and Oral Anti-diabetic Drugs","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2016-09-21","conditions":"Diabetes, Diabetes Mellitus, Type 2","enrollment":210},{"nctId":"NCT02911311","phase":"NA","title":"Conbercept vs Panretinal Photocoagulation for the Management of Proliferative Diabetic Retinopathy","status":"UNKNOWN","sponsor":"Sun Yat-sen University","startDate":"2019-10-12","conditions":"Proliferative Diabetic Retinopathy","enrollment":226},{"nctId":"NCT01455415","phase":"PHASE3","title":"Effect Of Pregabalin Treatment In Patients With Diabetic Nerve Pain Who Currently Use A Non-Steroid Anti-Inflammatory Drug (NSAID) For Another Pain","status":"COMPLETED","sponsor":"Pfizer's Upjohn has merged with Mylan to form Viatris Inc.","startDate":"2011-12","conditions":"Painful Diabetic Peripheral Neuropathy","enrollment":306},{"nctId":"NCT02983188","phase":"PHASE2, PHASE3","title":"Berberine as Adjuvant Treatment for Schizophrenia Patients","status":"COMPLETED","sponsor":"The University of Hong Kong","startDate":"2018-04-25","conditions":"Schizophrenia, Schizophrenia Spectrum and Other Psychotic Disorders, Metabolic Syndrome x","enrollment":113}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":501,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"Anti-diabetic medications","genericName":"Anti-diabetic medications","companyName":"Aristotle University Of Thessaloniki","companyId":"aristotle-university-of-thessaloniki","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Anti-diabetic medications work through various mechanisms to lower blood glucose levels by enhancing insulin secretion, improving insulin sensitivity, or reducing hepatic glucose production. Used for Type 2 diabetes mellitus, Type 1 diabetes mellitus (insulin-based therapies).","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}